Suchergebnisse - "Drug Repositioning"

PubPharm (97)

21

Prospect of Anterior Gradient 2 homodimer inhibition via repurposing FDA-approved drugs using structure-based virtual screening

enthalten in: Molecular diversity | 2021

von Ullah, S. | Khan, S. | Khan, A. | +6

22

KG-DTI: a knowledge graph based deep learning method for drug-target interaction predictions and Alzheimer’s disease drug repositions

enthalten in: Applied intelligence | 2021

von Wang, S. | Du, Z. | Ding, M. | +2

23

Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis

enthalten in: Medical microbiology and immunology | 2021

von Costa, R. | Oliveira-da-Silva, J. | Reis, T. | +18

24

COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics—a review

enthalten in: Archives of microbiology | 2021

von Raj, C. | Kandaswamy, D. | Danduga, R. | +2

25

Raloxifene as a treatment option for viral infections

enthalten in: The journal of microbiology | 2021

von Hong, S. | Chang, J. | Jeong, K. | +1

26

A Prospective Study on Metronomic Scheduling of Non-chemotherapeutic Drugs in Advanced Epithelial Ovarian Cancers

enthalten in: Indian journal of surgical oncology | 2021

von Shivdas, S. | Rajatharangani, T. | Rathod, P. | +5

27

Repositioning antispasmodic drug Papaverine for the treatment of chronic myeloid leukemia

enthalten in: Pharmacological reports | 2021

von Parcha, P. | Sarvagalla, S. | Ashok, C. | +4

28

COVID-19: Analysis of Drug Repositioning Practice

enthalten in: Pharmaceutical chemistry journal | 2021

von Savosina, P. | Druzhilovskii, D. | Poroikov, V.

29

Chloroquine and Hydroxychloroquine for the Treatment of COVID-19 : Review and Appraisal of Current Evidence

enthalten in: Journal of National Black Nurses' Association : JNBNA | 2020

von Powell-Young, Y. | Alzaghari, O. | Reyes-Miranda, C. | +6

30

Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma

enthalten in: Investigational new drugs | 2020

von Dell’Anno, I. | Martin, S. | Barbarino, M. | +11